REFERENCES
- Xu XM, Zhou YQ, Luo GX, . The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522.
- Cao A. Carrier screening and genetic counseling in β-thalassemia. Int J Hematol. 2002;76(Suppl. 2):105–113.
- Modell M, Modell B. Genetic screening for ethnic minorities. BMJ. 1990;300(6741):1702–1704.
- Chan LC, Ma SK, Chan AY, . Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia? J Clin Pathol. 2001;54(4):317–320.
- Li D, Liao C, Li J, . Prenatal diagnosis of β-thalassemia by reverse dot-blot hybridization in southern China. Hemoglobin. 2006;30(3):365–70.
- Leung KY, Lee CP, Tang MH, . Cost-effectiveness of prenatal screening for thalassemia in Hong Kong. Prenat Diagn. 2004;24(11):899–907.
- Ma ESK, Chan AYY, Ha SY, Lau YL, Chan LC. Thalassemia screening based on red cell indices in the Chinese. Haematologica. 2001;86(12):1310–1311.
- Rund D, Filon D, Strauss N, Rachmilewitz EA, Oppenheim A. Mean corpuscular volume of heterozygotes for β-thalassemia correlates with the severity of mutations. Blood. 1992;79(1):238–243.
- Lewis D, Stockley RJ, Chanarin I. Changes in the mean corpuscular red cell volume in women with β-thalassaemia trait during pregnancy. Br J Haematol. 1982;50(3):423–425.
- Bain BJ. Screening of antenatal patients in a multiethnic community for β thalassemia trait. J Clin Pathol. 1988;41(5):481–485.
- World Health Organization Working Group on Hemoglobinopathies. Guidelines for the control of hemoglobin disorders. Geneva: World Health organization. 1994.
- British Committee for Standards in Haematology. Guideline. The laboratory diagnosis of haemoglobinopathies. Br J Haematol. 1998;101(4):783–792.